Palomar (PLMR) Rule 144 Notice Shows Recent 10b5-1 Sales
Rhea-AI Filing Summary
Palomar Holdings, Inc. (PLMR) Form 144 notice reports proposed and recent sales of common stock by holders associated with the ARMSTRONG FAMILY TRUST. The filer lists a proposed sale of 5,000 shares to be executed on 09/22/2025 through Morgan Stanley Smith Barney LLC, with an aggregate market value of $579,200 based on the filing. The trust acquired 5,000 of those shares as restricted stock units on 07/15/2023. The filing also discloses four sales during the past three months totaling 18,191 shares with gross proceeds shown for each sale (largest listed proceeds $790,694.50 on 06/23/2025). The notice includes the required representation about absence of undisclosed material nonpublic information and references reliance on Rule 10b5-1 sales plans for some transactions.
Positive
- Compliance with Rule 144 and 10b5-1 is documented, showing procedural adherence for planned insider sales
- Transaction detail provided (share counts, dates, gross proceeds) enables transparent investor scrutiny
Negative
- Insider sell volume is non-trivial: 23,191 shares disclosed (past three months plus proposed sale), which represents a measurable disposition against 26,783,465 outstanding shares
- No context on intent or company performance is provided, so sales could be interpreted negatively despite procedural compliance
Insights
TL;DR Recent and planned insider sales total 23,191 shares, indicating ownership dispositions via 10b5-1 plans.
The filing documents a proposed sale of 5,000 shares valued at $579,200 and prior 10b5-1 and trust sales totaling 18,191 shares in the past three months with reported gross proceeds for each trade. The filer identifies acquisition of 5,000 shares as restricted stock units on 07/15/2023, which were later sold under disclosed plans. From an analytical perspective, the filing presents clear transactional detail—quantities, proceeds, and dates—allowing investors to quantify insider liquidity events relative to the issuer's reported outstanding shares of 26,783,465. The data are factual and permit calculation of insider sell volumes as a percentage of outstanding shares, but the filing contains no information about motivations or company performance.
TL;DR The filer used 10b5-1 plans and a Rule 144 notice, demonstrating procedural compliance for scheduled insider sales.
The document shows reliance on Rule 10b5-1 sales arrangements for several transactions and includes the required attestations under Form 144 regarding material nonpublic information. This indicates the selling parties followed standard disclosure and planning procedures to lawfully effect dispositions of restricted awards and trust holdings. The filing does not disclose any departures from governance norms or unexpected executive actions; it is a routine compliance filing reporting insider liquidity rather than operational developments.